Cellectar Biosciences Price to Free Cash Flow Ratio 2010-2024 | CLRB
Historical price to free cash flow ratio values for Cellectar Biosciences (CLRB) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cellectar Biosciences Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-01-17 | 0.24 | 0.00 | |
| 2024-09-30 | 2.14 | $-1.58 | 0.00 |
| 2024-06-30 | 2.50 | $-2.15 | 0.00 |
| 2024-03-31 | 3.98 | $-2.54 | 0.00 |
| 2023-12-31 | 2.77 | $-2.72 | 0.00 |
| 2023-09-30 | 2.64 | $-2.74 | 0.00 |
| 2023-06-30 | 1.95 | $-3.13 | 0.00 |
| 2023-03-31 | 1.43 | $-3.42 | 0.00 |
| 2022-12-31 | 1.71 | $-3.61 | 0.00 |
| 2022-09-30 | 3.36 | $-4.82 | 0.00 |
| 2022-06-30 | 4.04 | $-4.89 | 0.00 |
| 2022-03-31 | 6.88 | $-4.92 | 0.00 |
| 2021-12-31 | 6.64 | $-7.31 | 0.00 |
| 2021-06-30 | 11.90 | $-4.48 | 0.00 |
| 2021-03-31 | 16.10 | $-4.30 | 0.00 |
| 2020-12-31 | 20.80 | $-7.06 | 0.00 |
| 2020-09-30 | 12.40 | $-16.09 | 0.00 |
| 2020-06-30 | 12.80 | $-10.44 | 0.00 |
| 2020-03-31 | 13.33 | $-11.14 | 0.00 |
| 2019-12-31 | 22.50 | $-9.36 | 0.00 |
| 2021-09-30 | 9.25 | $-3.02 | 0.00 |
| 2019-09-30 | 20.00 | $-22.19 | 0.00 |
| 2019-06-30 | 21.80 | $-14.52 | 0.00 |
| 2019-03-31 | 23.50 | $-26.70 | 0.00 |
| 2018-12-31 | 15.50 | $-39.74 | 0.00 |
| 2018-09-30 | 30.00 | $-44.78 | 0.00 |
| 2018-06-30 | 62.00 | $-69.75 | 0.00 |
| 2018-03-31 | 113.50 | $-74.54 | 0.00 |
| 2017-12-31 | 137.00 | $-81.01 | 0.00 |
| 2017-09-30 | 167.00 | $-144.10 | 0.00 |
| 2017-06-30 | 163.00 | $-149.64 | 0.00 |
| 2017-03-31 | 227.00 | $-16.15 | 0.00 |
| 2016-12-31 | 122.00 | $-191.33 | 0.00 |
| 2016-09-30 | 271.00 | $-274.86 | 0.00 |
| 2016-06-30 | 344.00 | $-537.24 | 0.00 |
| 2016-03-31 | 341.83 | $-942.11 | 0.00 |
| 2015-12-31 | 735.00 | $-1,057.76 | 0.00 |
| 2015-09-30 | 1970.00 | $-1,484.77 | 0.00 |
| 2015-06-30 | 2880.00 | $-929.02 | 0.00 |
| 2015-03-31 | 3110.00 | $-1,338.28 | 0.00 |
| 2014-12-31 | 3090.00 | $-1,931.35 | 0.00 |
| 2014-09-30 | 2220.00 | $-2,364.69 | 0.00 |
| 2014-06-30 | 6390.00 | $-3,537.99 | 0.00 |
| 2014-03-31 | 7800.00 | $-3,464.71 | 0.00 |
| 2013-12-31 | 7400.00 | $-3,328.25 | 0.00 |
| 2013-09-30 | 7200.00 | $-3,276.90 | 0.00 |
| 2013-06-30 | 9200.00 | $-4,649.33 | 0.00 |
| 2013-03-31 | 9200.00 | $-4,023.08 | 0.00 |
| 2012-12-31 | 14800.00 | $-3,250.26 | 0.00 |
| 2012-09-30 | 21000.00 | $-2,277.13 | 0.00 |
| 2012-06-30 | 23800.00 | $-0.22 | 0.00 |
| 2012-03-31 | 17000.00 | $-0.28 | 0.00 |
| 2011-12-31 | 8800.00 | $-0.25 | 0.00 |
| 2011-09-30 | 25400.00 | $-866.76 | 0.00 |
| 2011-06-30 | 26000.00 | $-866.76 | 0.00 |
| 2011-03-31 | 61200.00 | $-863.11 | 0.00 |
| 2010-12-31 | 91800.00 | $-866.85 | 0.00 |
| 2010-09-30 | 153000.00 | $-0.26 | 0.00 |
| 2010-06-30 | 336600.00 | $-0.21 | 0.00 |
| 2010-03-31 | 550800.00 | $-3.76 | 0.00 |
| 2009-12-31 | 7772400.00 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.010B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| ResMed (RMD) | United States | $35.199B | 28.92 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Prestige Consumer Healthcare (PBH) | United States | $3.882B | 19.31 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.245B | 51.20 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.56 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.87 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |